translational research

Great Hall - Strand Campus, London, United Kingdom

29 March 2019

See more informations here: https://www.eacr.org/meeting/bladder-cancer-translational-research-meeting-an-unmet-clinical-and-research-need

Great Hall - Strand Campus, London, United Kingdom

29 March 2019

See more informations here: https://www.eacr.org/meeting/bladder-cancer-translational-research-meeting-an-unmet-clinical-and-research-need

Fira, Barcelona, Spain

27 September - 01 October, 2019

See more informations here: https://www.esmo.org/Conferences/ESMO-2019-Congress

Fira, Barcelona, Spain

27 September - 01 October, 2019

See more informations here: https://www.esmo.org/Conferences/ESMO-2019-Congress

Auditorio Rafael del Pino, Madrid, Spain

23 - 24 February, 2018

See more informations here: http://www.innovationinbreastcancer.com/

Auditorio Rafael del Pino, Madrid, Spain

23 - 24 February, 2018

See more informations here: http://www.innovationinbreastcancer.com/

Tel-Aviv, Israel

4 June 2015

See more informations here: http://www.iscr.org.il/124131/English

Tel-Aviv, Israel

4 June 2015

See more informations here: http://www.iscr.org.il/124131/English

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call:

TRANSCAN-2 is launching its first Joint Transnational Call for research proposals (JTC 2014) to which the European Commission (EC) will contribute. TRANSCAN-2 has the goal of coordinating national and regional funding programmes for research in the area of translational cancer research.

The topic of the call will be «Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy» and projects must cover at least one of the areas specified below, which are equal in relevance for this call: